1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Implementing data on targeted therapy from the INFORM registry platform for children with relapsed cancer in Sweden
(
- Contribution to journal › Article
- 2022
-
Mark
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
(
- Contribution to journal › Article
-
Mark
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
(
- Contribution to journal › Article
- 2021
-
Mark
NTRK Alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets
(
- Contribution to journal › Letter
-
Mark
The pediatric precision oncology INFORM registry : clinical outcome and benefit for patients with very high-evidence targets
(
- Contribution to journal › Article